This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christou, H.
Right arrow Articles by Kourembanas, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christou, H.
Right arrow Articles by Kourembanas, S.
Related Collections
Right arrow Premature & Newborn

PEDIATRICS Vol. 102 No. 6 December 1998, pp. 1390-1393

Inhaled Nitric Oxide Does Not Affect Adenosine 5'-Diphosphate-dependent Platelet Activation in Infants With Persistent Pulmonary Hypertension of the Newborn

Received Jan 8, 1998; accepted May 26, 1998.

Helen Christou*, Dagger , **, Barbarajean Magnaniparallel , Dagger Dagger , David S. MorseDagger Dagger , Elizabeth N. Allred#, §§, Linda J. Van Marter*, Dagger , **, David L. Wessel§, , and Stella Kourembanas*, Dagger , **

From the Divisions of * Newborn Medicine and Dagger  Developmental and Newborn Biology, the Departments of § Anesthesia, parallel  Laboratory Medicine and Pathology,  Cardiology, and # Neurology, Children's Hospital; the Departments of ** Newborn Medicine and Dagger Dagger  Anesthesia, Brigham and Women's Hospital, Harvard Medical School; and the §§ Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts.

Objective.  To investigate the effect of inhaled nitric oxide (NO) treatment in newborns with persistent pulmonary hypertension on adenosine 5'-diphosphate (ADP)-dependent platelet activation.

Methods.  After parental informed consent, infants with persistent pulmonary hypertension of the newborn were randomly assigned to receive conventional treatment (control group) or treatment with 40 parts per million of inhaled NO. Platelet activation was measured at time of entry and 30 minutes later by surface expression of P-selectin in response to increasing concentrations of the agonist ADP (0, 2, 5, 10, and 20 µM) using fluorescence-activated flow cytometry.

Results.  We examined 11 infants in the inhaled NO group and 13 in the control group. P-selectin expression, quantified as mean fluorescence, was not significantly different in the two groups of patients at baseline. Median percent change from baseline fluorescence was assessed using the Wilcoxon matched-pairs signed-rank test. At 30 minutes after enrollment there were no statistically significant changes from baseline fluorescence in either group of patients and at all ADP concentrations.

Conclusion.  Thirty minutes of exposure to 40 ppm of inhaled NO does not inhibit ADP-dependent platelet activation as measured by surface expression of P-selectin in infants with persistent pulmonary hypertension of the newborn.  Key words:  platelet function, bleeding, hemostasis.




This article has been cited by other articles:


Home page
 NEJMHome page
K. P. Van Meurs, L. L. Wright, R. A. Ehrenkranz, J. A. Lemons, M. B. Ball, W. K. Poole, R. Perritt, R. D. Higgins, W. Oh, M. L. Hudak, et al.
Inhaled Nitric Oxide for Premature Infants with Severe Respiratory Failure
N. Engl. J. Med., July 7, 2005; 353(1): 13 - 22.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
K. P. Van Meurs
Inhaled Nitric Oxide Therapy in the Preterm Infant Who Has Respiratory Distress Syndrome
NeoReviews, June 1, 2005; 6(6): e268 - e277.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Beghetti, C. Sparling, P. N. Cox, D. Stephens, and I. Adatia
Inhaled NO inhibits platelet aggregation and elevates plasma but not intraplatelet cGMP in healthy human volunteers
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H637 - H642.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
N. N. Finer, J. W. Sun, W. Rich, E. Knodel, and K. J. Barrington
Randomized, Prospective Study of Low-Dose Versus High-Dose Inhaled Nitric Oxide in the Neonate With Hypoxic Respiratory Failure
Pediatrics, October 1, 2001; 108(4): 949 - 955.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. Ellington Jr, D. O'Reilly, E. N. Allred, M. C. McCormick, D. L. Wessel, and S. Kourembanas
Child Health Status, Neurodevelopmental Outcome, and Parental Satisfaction in a Randomized, Controlled Trial of Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn
Pediatrics, June 1, 2001; 107(6): 1351 - 1356.
[Abstract] [Full Text] [PDF]